Sandip Pravin Patel
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 83
- Cancer Immunotherapy and Biomarkers 51
- CAR-T cell therapy research 15
- Lung Cancer Research Studies 15
- Colorectal Cancer Treatments and Studies 9
-
- Lung Cancer Treatments and Mutations 36
- Lung Cancer Diagnosis and Treatment 11
- Co-authors
- Razelle Kurzrock (33 shared papers)Aaron Michael Goodman (5 shared papers)Lyudmila A. Bazhenova (7 shared papers)Gregory A. Daniels (8 shared papers)Shumei Kato (5 shared papers)Garrett Michael Frampton (2 shared papers)Vincent A. Miller (2 shared papers)Philip J. Stephens (1 shared paper)
- Journals
- Journal of the National Comprehensive Cancer Network (14 papers)Clinical Cancer Research (14 papers)Journal for ImmunoTherapy of Cancer (10 papers)Annals of Oncology (10 papers)Journal of Thoracic Oncology (7 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Sandip Pravin Patel
175 papers receiving 14.3k citations
Sandip Pravin Patel's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 6.8k
- Cancer Research 2.1k
- Pulmonary and Respiratory Medicine 4.1k
- Immunology 2.1k
- Pathology and Forensic Medicine 817
Countries citing papers authored by Sandip Pravin Patel
This map shows the geographic impact of Sandip Pravin Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandip Pravin Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandip Pravin Patel more than expected).
Fields of papers citing papers by Sandip Pravin Patel
This network shows the impact of papers produced by Sandip Pravin Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandip Pravin Patel. The network helps show where Sandip Pravin Patel may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandip Pravin Patel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy Hit paper breakdown → | 2015 | 1909 |
| 2 | Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers Hit paper breakdown → | 2017 | 1816 |
| 3 | Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 1007 |
| 4 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 Hit paper breakdown → | 2021 | 756 |
| 5 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020 Hit paper breakdown → | 2019 | 722 |
| 6 | Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 469 |
| 7 | ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment Hit paper breakdown → | 2020 | 462 |
| 8 | Non–Small Cell Lung Cancer, Version 4.2024 Hit paper breakdown → | 2024 | 423 |
| 9 | NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 Hit paper breakdown → | 2020 | 411 |
| 10 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018 Hit paper breakdown → | 2018 | 402 |
| 11 | Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions Hit paper breakdown → | 2022 | 391 |
| 12 | 2016 | 390 | |
| 13 | NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 Hit paper breakdown → | 2023 | 339 |
| 14 | Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 334 |
| 15 | A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors Hit paper breakdown → | 2020 | 266 |
| 16 | 2019 | 229 | |
| 17 | 2004 | 184 | |
| 18 | 2017 | 174 | |
| 19 | 2019 | 143 | |
| 20 | Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC Hit paper breakdown → | 2023 | 139 |
About Sandip Pravin Patel
Sandip Pravin Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Pathology and Forensic Medicine, having authored 189 papers that have together received 14.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (51 papers), Lung Cancer Treatments and Mutations (36 papers), Cancer Genomics and Diagnostics (16 papers), CAR-T cell therapy research (15 papers), Lung Cancer Research Studies (15 papers), Lung Cancer Diagnosis and Treatment (11 papers), Immunotherapy and Immune Responses (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). The work is most often cited by research in Oncology (6.8k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (4.1k citations), Immunology (2.1k citations) and Pathology and Forensic Medicine (817 citations). Sandip Pravin Patel has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Razelle Kurzrock, Aaron Michael Goodman, Lyudmila A. Bazhenova, Gregory A. Daniels, Shumei Kato, Garrett Michael Frampton, Vincent A. Miller, Philip J. Stephens, Yulian Khagi and Kriti Agrawal. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Annals of Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.